These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18261479)

  • 1. Impact of statin dosing intensity on transaminase and creatine kinase.
    Gosmanov AR; Lewis JB
    Am J Med; 2008 Feb; 121(2):e11; author reply e13. PubMed ID: 18261479
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of statin dosing intensity on transaminase and creatine kinase.
    Dale KM; White CM; Henyan NN; Kluger J; Coleman CI
    Am J Med; 2007 Aug; 120(8):706-12. PubMed ID: 17679130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentials and pitfalls of meta-analysis on statins.
    Lotrionte M; Agostoni P; Biondi-Zoccai GG
    Am J Med; 2008 Jan; 121(1):e3; author reply e5. PubMed ID: 18187058
    [No Abstract]   [Full Text] [Related]  

  • 4. Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force.
    McKenney JM; Davidson MH; Jacobson TA; Guyton JR;
    Am J Cardiol; 2006 Apr; 97(8A):89C-94C. PubMed ID: 16581336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An assessment of statin safety by muscle experts.
    Thompson PD; Clarkson PM; Rosenson RS;
    Am J Cardiol; 2006 Apr; 97(8A):69C-76C. PubMed ID: 16581332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver transaminase levels alone could not be the optimal method to estimate hepatic safety after statin administration in patients with chronic kidney disease.
    Molino C; Tiseo R; De Giorgi A; Pala M; Manfredini R
    Am Heart J; 2011 Jul; 162(1):e15. PubMed ID: 21742076
    [No Abstract]   [Full Text] [Related]  

  • 7. [Creatine kinase increase under simvastatin--therapeutic consequences?].
    Rasche-Schürmann CC; Picksak G; Stichtenoth DO
    Med Monatsschr Pharm; 2008 Jan; 31(1):25-7. PubMed ID: 18522017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid-altering efficacy of ezetimibe/simvastatin 10/40 mg compared with doubling the statin dose in patients admitted to the hospital for a recent coronary event: the INFORCE study.
    Reckless JP; Henry P; Pomykaj T; Lim ST; Massaad R; Vandormael K; Johnson-Levonas AO; Lis K; Brudi P; Allen C
    Int J Clin Pract; 2008 Apr; 62(4):539-54. PubMed ID: 18266852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing statin myopathy.
    Venero CV; Thompson PD
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):121-36. PubMed ID: 19217515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggressive statin therapy in multicenter and effectiveness for the reduction of intra-myocardial damage caused by non-ST elevation acute coronary syndrome: AMERICA study.
    Hara H; Nakamura M; Yokouchi I; Kimura K; Nemoto N; Ito S; Ono T; Itaya H; Shiba M; Wada M; Iijima R; Yamamoto M; Yamamoto M; Hara H; Takagi T; Asahara T; Mitsuo K; Kobayashi N; Sugi K
    Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):357-65. PubMed ID: 19638365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Creatine kinase: a review of its use in the diagnosis of muscle disease.
    Gasper MC; Gilchrist JM
    Med Health R I; 2005 Nov; 88(11):398, 400-4. PubMed ID: 16363394
    [No Abstract]   [Full Text] [Related]  

  • 12. Should high creatine kinase discourage the initiation or continuance of statins for the treatment of hypercholesterolemia?
    Glueck CJ; Rawal B; Khan NA; Yeramaneni S; Goldenberg N; Wang P
    Metabolism; 2009 Feb; 58(2):233-8. PubMed ID: 19154957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which statin?
    Med Lett Drugs Ther; 2008 Apr; 50(1284):29-31. PubMed ID: 18425054
    [No Abstract]   [Full Text] [Related]  

  • 14. Study finds small association between statin use and musculoskeletal conditions.
    Wise J
    BMJ; 2013 Jun; 346():f3609. PubMed ID: 23737283
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial.
    Mannacio VA; Iorio D; De Amicis V; Di Lello F; Musumeci F
    J Thorac Cardiovasc Surg; 2008 Dec; 136(6):1541-8. PubMed ID: 19114204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of statin-associated myotoxicity by L-carnitine.
    Arduini A; Peschechera A; Giannessi F; Carminati P
    J Thromb Haemost; 2004 Dec; 2(12):2270-1. PubMed ID: 15613049
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of chronic statin pretreatment on hospital outcome in patients with acute non-ST-elevation myocardial infarction.
    Bauer T; Böhm M; Zahn R; Jünger C; Koeth O; Gitt A; Bestehorn K; Senges J; Zeymer U;
    J Cardiovasc Pharmacol; 2009 Feb; 53(2):132-6. PubMed ID: 19188836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose statin therapy: benefits and safety in aggressive lipid lowering.
    Toth PP; Davidson MH
    J Fam Pract; 2008 May; 57(5 Suppl High-Dose):S29-36. PubMed ID: 18662521
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectiveness and tolerability of every-other-day rosuvastatin dosing in patients with prior statin intolerance.
    Backes JM; Venero CV; Gibson CA; Ruisinger JF; Howard PA; Thompson PD; Moriarty PM
    Ann Pharmacother; 2008 Mar; 42(3):341-6. PubMed ID: 18285559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive statin therapy in coronary artery disease: is lower cholesterol better and safe?
    Seshasai SR; Ray KK
    Future Cardiol; 2009 Mar; 5(2):129-39. PubMed ID: 19371188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.